Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-11-01
1999-06-29
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514778, 514784, 514785, 536 48, 536103, 536119, 525 542, A61K 4740, C08B 3716, C07H 1308
Patent
active
059168838
ABSTRACT:
A cyclodextrin derivative, wherein at least 60 percent of the free hydroxy groups of said cyclodextrin are acylated with acyl groups where at least one of said acyl groups comprise a free carboxylic group.
REFERENCES:
patent: 3426011 (1969-02-01), Parmerter et al.
patent: 3453260 (1969-07-01), Parmerter et al.
patent: 4670419 (1987-06-01), Uda et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4869904 (1989-09-01), Uekama et al.
patent: 5208316 (1993-05-01), Yoshinaga
patent: 5241059 (1993-08-01), Yoshinaga
patent: 5247013 (1993-09-01), Shinoda et al.
Zhong-Yao Shen et al., Carbohydrate Research, vol. 201, No. 2, Jul. 1, 1990, pp. 241-247.
Croft, A.P., and Bartsch, R.A., Synthesis of Chemically Modified Cyclodextrins, Tetrahedron, vol. 39, No. 9, pp. 1417-1474, (1983).
Breslow et al., "Additional Flexibility Solves the Leaving Group Problem in Cyclodextrin Acylation", Tetrahedron Letters 31:631-634, 1990.
Breslow et al., "Improved Acylation Rates within Cyclodextrin Complexes from Flexible Capping of the Cyclodextrin and from Adjustment of the substrate Geometry", J. of American Chem. Society 102:762-770, 1980.
Coates et al., "Complementary Diastereoselectivity in the Synthesis and Hydrolysis of Acylated Cyclodextrins" Chemistry Letters pp. 1153-1156, 1994.
Czarniecki et al., "Very Fast Acylation of .beta.-Cyclodextrin by Bound p-Nitrophenyl Ferrocinnamate", J. of American Chemical Society 100:7771-7772, 1978.
Hirayama et al., "Characterization of Peracylated .beta.-Cyclodextrins with Different Chain Lengths as a Novel Sustained Release Carrier for Water-Soluble Drugs", Chem. Pharm. Bull. 43:130-136, 1995.
Hirayama et al., "Utilization of Diethyl-.beta.-cyclodextrin as a Sustained-Release Carrier for Isosorbide Dinitrate", J. of Pharmaceutical Sciences 77:233-236, 1988.
Horiuchi et al., "Slow-Release Characteristics of Diltiazem from Ethylated .beta.-Cyclodextrin Complexes", J. of Pharmaceutical Sciences 79:128-132, 1990.
Liu et al., "Complexation of 6-Acyl-O-.beta.-Cyclodextrin Derivatives with Steroids--Effect of Chain Length and Substitution Degree", Drug Devel. and Industrial Pharmacy 18:1599-1612, 1992.
Matsubara et al., "Possible Use of Triacetylated Cyclodextrins in the Preparation of Sustained-Release Only Injection of . . . ", J. Minutes Int. Symp. Cyclodextrins, 6th Editor pp. 547-550, 1992.
Ryoshi et al., "Two-phase (water/organic) Free Radical Polymerization of Water-Soluble Vinyl Monomers Using Lipophilic Acylated . . . ", Makromol. Chem. 187:263-271, 1986.
Sugiura et al., "Immobilized .beta.-Cyclodextrins. Preparation with Various Crosslinking Reagents and the Guest Binding Properties", The Chem. Society of Japan Bull. Chem. Soc. Jpn. 62:1643-1651, 1989.
Tanaka et al., "Unmodified and Acylated Cycledextrin Stationary Phases for Liquid Chromatographic Separation of Aromatic Compounds", Journal of Chromatography 301:345-353, 1984.
Thiem et al., "Molecular Modeling Calculations on the Acylation of .beta.-Cyclodextrin by Ferrocenylacrylate Esters", J. Am. Chem. Soc. 110:8612-8616, 1988.
Torres-Labandeira et al., "Use of Cyclodextrins In Sustained-Release Nifedipine Formulations", Journal Minutes Int. Symp. Cyclodextrins, 6th Editor pp. 563-566, 1992.
Trainer et al., "High Acylation Rates and Enantioselectivity with Cyclodextrin Complexes of Rigid Substrates" J. Am. Chem. Soc. 103:154-158, 1981.
Uekama et al., "Design and In Vitro Evaluation of Slow-Release Dosage Form of Piretanide: Utility of .beta.Cyclodextrin: Cellulose . . . ", Journal of Pharmaceutical Sciences 79:244-248, 1990.
Uekama et al., Ethylated .beta.-Cyclodextrins as Hydrophobic Drug Carriers: Sustained Released of Diltiazem in the Rat, Journal of Pharmaceutical Sciences 76:660-661, 1987.
Uekama et al., "Peracylated .beta.-Cyclodextrins as Novel Sustained-release Carriers for a Water-soluble Drug, Molsidomine", J. Pharm. Pharmacol. 46:714-717, 1994.
Uekama et al., "Sustained Release of Buserelin Acetate, a Luteinizing Hormone-releasing Hormone Agonist, from an Injectable Oily Preparation . . . ", J. Pharm. Pharmcol. 41:874-876, 1989.
Corbett Joel Thomas
Shalaby Shalaby W.
Conway John D.
McGowan William
Poly-Med, Inc.
Webman Edward J.
LandOfFree
Acylated cyclodextrin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated cyclodextrin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated cyclodextrin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375559